SANTA ANA, Calif., May 24 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) , a global leader in ophthalmic surgical devices and eye care products, will host an Analyst Day on June 8, 2006, in Huntington Beach, California.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO )
Management presentations will begin at 8:30 a.m. (PT) and will include an overview of AMO, its growth strategy and market potential, and discussions of how strategy execution delivers improved financial performance. AMO presenters will include James V. Mazzo, president and chief executive officer, and Richard A. Meier, executive vice president, operations; president, eye care business; and chief financial officer.
A series of panel discussions with practitioners and AMO experts in research and development and marketing will highlight AMO products, pipeline, opportunities and market approach.
To access the live webcast please visit the company's Investors site at www.amo-inc.com. Replay will also be available on demand from the website at the conclusion of the program and will run through June 15, 2006.
About Advanced Medical Optics (AMO)
AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Clariflex(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4 IR(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(R) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(TM) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,600 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at www.amo-inc.com.
Investor Contact: Erika Richmond (714) 247-8348 erika.richmond@amo-inc.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comAdvanced Medical Optics, Inc.CONTACT: Investors, Erika Richmond of Advanced Medical Optics, Inc.,+1-714-247-8348, erika.richmond@amo-inc.com
Web site: http://www.amo-inc.com//
